Oral vaccine for norovirus shows promise in Phase 1b trial Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.

https://www.drugdiscoverynews.com/oral-vaccine-for-norovirus-shows-promise-in-phase-1b-trial-16318?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz--W1uejdW4Ci6juobt-09SPt-Cxeae_ni6hzGjo09AbimjrKR6d1UDdm-hl7ctx5ytnynJMqipwFvFEBbfnvmcS9D4Khg&_hsmi=384889687&utm_content=384889687&utm_source=hs_email